Clinical Trial Update: A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of JL15003 Injection in Patients With Recurrent Glioblastoma (rGBM) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase Ib/II study of JL15003 injection for recurrent glioblastoma and notes that the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• JL15003 injection (JL15003)

Snippet

Sponsor: Jecho Biopharmaceuticals Co., Ltd. | Conditions: Recurrent Glioblastoma Multiforme(GBM) | Phase 1, Phase 2 | Status: RECRUITING